Detalhe da pesquisa
1.
MS becomes a treatable disease: 30 years later.
Mult Scler
; 29(7): 789-792, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232509
2.
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis.
Mult Scler
; 29(1): 92-106, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36113170
3.
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset.
Mult Scler
; 29(14): 1776-1785, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37830451
4.
Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community.
Mult Scler
; 29(11-12): 1363-1372, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691493
5.
How patients with multiple sclerosis acquire disability.
Brain
; 145(9): 3147-3161, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35104840
6.
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis.
Mult Scler
; 28(4): 608-619, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378456
7.
Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosis.
Eur J Neurol
; 29(4): 1106-1116, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927308
8.
Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosis.
Mult Scler
; 27(4): 568-578, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32567468
9.
Depression and cognitive function in early multiple sclerosis: Multitasking is more sensitive than traditional assessments.
Mult Scler
; 27(8): 1276-1283, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196404
10.
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Lancet
; 394(10206): 1352-1363, 2019 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495497
11.
Deep Learning for Predicting Enhancing Lesions in Multiple Sclerosis from Noncontrast MRI.
Radiology
; 294(2): 398-404, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31845845
12.
Deep-Learning-Based Neural Tissue Segmentation of MRI in Multiple Sclerosis: Effect of Training Set Size.
J Magn Reson Imaging
; 51(5): 1487-1496, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31625650
13.
Brain and lesion segmentation in multiple sclerosis using fully convolutional neural networks: A large-scale study.
Mult Scler
; 26(10): 1217-1226, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31190607
14.
Word-finding difficulty is a prevalent disease-related deficit in early multiple sclerosis.
Mult Scler
; 26(13): 1752-1764, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31741430
15.
Early complement genes are associated with visual system degeneration in multiple sclerosis.
Brain
; 142(9): 2722-2736, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289819
16.
Worsening MS-A reappraisal of how we characterize the MS disease course.
Mult Scler
; 29(14): 1699-1700, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850489
17.
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.
Brain
; 138(Pt 3): 517-39, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25636970
18.
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Hum Brain Mapp
; 36(10): 3749-3760, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26096844
19.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Brain
; 137(Pt 8): 2271-86, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24893707
20.
Randomized study combining interferon and glatiramer acetate in multiple sclerosis.
Ann Neurol
; 73(3): 327-40, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23424159